(Q44200258)

English

The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit

scientific article published in November 2011

Statements

The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit (English)
Georgios F Samelis
Konstantinos A Ekmektzoglou
Andriani Tsiakou
Manousos Konstadoulakis

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit